Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    1901 Apheresis Allogeneic Acute lymphoblastic leukemia Hematology 2024 Standard Therapy Germany 50
    1902 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 57
    1903 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 70
    1904 Apheresis Allogeneic Multiple Organ Dysfunction Syndrome Hematology 2024 Standard Therapy Germany 42
    1905 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 32
    1906 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 76
    1907 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2024 Standard Therapy Italy 63
    1908 Apheresis Allogeneic Early T-cell precursor Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Australia 43
    1909 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 72
    1910 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 72
    1911 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 52
    1912 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 73
    1913 Apheresis Allogeneic Myelofibrosis Hematology 2024 Standard Therapy Poland 68
    1914 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 63
    1915 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Czechia 46
    1916 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 64
    1917 Apheresis Allogeneic Primary Immunodeficiencies Hematology 2024 Standard Therapy Russia 7
    1918 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 68
    1919 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 62
    1920 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 48
    1921 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 63
    1922 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2024 Standard Therapy Spain 58
    1923 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 41
    1924 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2024 Standard Therapy USA 73
    1925 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 15
    1926 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 65
    1927 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 38
    1928 Apheresis Allogeneic Plasmacytoma Hematology 2024 Standard Therapy Poland 46
    1929 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Portugal 60
    1930 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Portugal 60
    1931 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2023 Experimental Therapy Poland 8
    1932 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2023 Experimental Therapy Poland 16
    1933 Cord Tissue Allogeneic – Related Ags (Autism + Epilepsy) Neurology 2023 Experimental Therapy Poland/Romania 15
    1934 Cord Tissue Allogeneic – Related Autism Neurology 2023 Experimental Therapy Romania 8,5
    1935 Cord Tissue Autologous Autism Neurology 2023 Experimental Therapy Hungary 10
    1936 Cord Tissue Allogeneic – Related Autism Neurology 2023 Experimental Therapy Romania 4
    1937 Cord Tissue Allogeneic – Related Autism Neurology 2023 Experimental Therapy Romania 10
    1938 Cord Tissue Allogeneic – Related Autism Neurology 2023 Experimental Therapy Romania 3,2
    1939 Cord Tissue Autologous Cerebral Palsy Neurology 2023 Experimental Therapy Romania 2
    1940 Cord Tissue Allogeneic – Related Cerebral Palsy Neurology 2023 Experimental Therapy Romania 3
    1941 Cord Tissue Allogeneic – Unrelated Disorders Of Optic Nerve Ophthalmology 2023 Experimental Therapy Poland 39,1
    1942 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2023 Experimental Therapy Poland 65,1
    1943 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2023 Experimental Therapy Poland 50,8
    1944 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2023 Experimental Therapy Poland 8 months
    1945 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2023 Experimental Therapy Poland 16,2
    1946 Cord Tissue Allogeneic – Unrelated Internal Damage To The Knee Joint Orthopedy 2023 Experimental Therapy Poland 20,8
    1947 Cord Tissue Allogeneic – Unrelated Internal Damage To The Knee Joint Orthopedy 2023 Experimental Therapy Poland 49,8
    1948 Cord Tissue Allogeneic – Unrelated Internal Damage To The Knee Joint Orthopedy 2023 Experimental Therapy Poland 62,7
    1949 Cord Tissue Allogeneic – Unrelated Internal Damage To The Knee Joint Orthopedy 2023 Experimental Therapy Poland 24,1
    1950 Cord Tissue Allogeneic – Unrelated Mucopolysaccharidosis Type Ii Hematology 2023 Experimental Therapy Poland 4,7
    1951 Cord Tissue Allogeneic – Unrelated Non-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The Uterus Gynecology 2023 Experimental Therapy Poland 47
    1952 Cord Tissue Autologous Optic Nerve Atrophy, Tetraparesis, Hydrocephalus Neurology 2023 Experimental Therapy Romania 5,5
    1953 Cord Tissue Allogeneic – Unrelated Ovarian Dysfunction Gynecology 2023 Experimental Therapy Poland 44,8
    1954 Cord Tissue Allogeneic – Unrelated Ovarian Dysfunction Gynecology 2023 Experimental Therapy Poland 32,11
    1955 Cord Tissue Allogeneic – Unrelated Polycystic Ovary Syndrome Gynecology 2023 Experimental Therapy Poland 39,4
    1956 Cord Tissue Allogeneic – Related Right Parietal Closed Schizencephaly Neurology 2023 Experimental Therapy Romania 38
    1957 Cord Tissue Allogeneic – Related Rp+ Usher Syndrome Neurology 2023 Experimental Therapy Romania 10
    1958 Cord Tissue Allogeneic – Related Sudden Sensorineural Hearing Loss (Ssnhl) Neurology 2023 Experimental Therapy Romania 1
    1959 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Hungary 10
    1960 Cord Blood Allogeneic Autism Neurology 2023 Experimental Therapy Poland 3,3
    1961 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Romania 3
    1962 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Romania 3
    1963 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Romania 10
    1964 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Portugal 7
    1965 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Portugal 5
    1966 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Hungary 14
    1967 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Romania 10
    1968 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Hungary 3
    1969 Cord Blood Allogeneic – Related Autism Neurology 2023 Experimental Therapy Romania 3,2
    1970 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Hungary 5
    1971 Cord Blood Allogeneic – Related Beta Thalassemia Hematology 2023 Standard Therapy UK 8
    1972 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2023 Experimental Therapy Hungary 5
    1973 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2023 Standard Therapy UK 2,5
    1974 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2023 Standard Therapy UK 2,5
    1975 Cord Blood Autologous Cerebral Palsy Neurology 2023 Experimental Therapy Poland 2,1
    1976 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2023 Experimental Therapy Romania 10
    1977 Cord Blood Allogeneic – Related Cerebral Palsy, Psychomotor Retard, Tetraparesis, Microcephaly Neurology 2023 Experimental Therapy Romania 9
    1978 Cord Blood Autologous Global Developmental Delay Si Truncal Ataxia Neurology 2023 Experimental Therapy Romania 5
    1979 Cord Blood Allogeneic Neuroblastoma Hematology 2023 Standard Therapy Turkey 2,1
    1980 Cord Blood Allogeneic – Related Neuroblastoma Hematology 2023 Standard Therapy Turkey 2,1
    1981 Cord Blood Autologous Optic Nerve Atrophy, Tetraparesis, Hydrocephalus Neurology 2023 Experimental Therapy Romania 5,5
    1982 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2023 Experimental Therapy Poland 3,11
    1983 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2023 Experimental Therapy Poland 8,1
    1984 Cord Blood Allogeneic – Related Spasmodic Torticollis Neurology 2023 Experimental Therapy Romania 41
    1985 Cord Blood Allogeneic Thalassemia Major Hematology 2023 Standard Therapy Turkey 17,4
    1986 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2023 Standard Therapy Turkey 17,4
    1987 Cord Blood Allogeneic Wiskott-Aldrich Syndrome Hematology 2023 Standard Therapy Poland 5 months
    1988 Cord Blood Autologous Autism Neurology 2023 Experimental Therapy Slovakia 2
    1989 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 42
    1990 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 41
    1991 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 35
    1992 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 59
    1993 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 50
    1994 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 51
    1995 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 59
    1996 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 42
    1997 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 21
    1998 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 67
    1999 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 63
    2000 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 39